The levels of VEGF, FGF-2, fractalkine, and TGF-α seemed to be higher in cases than in controls 20 to 25 years prior to diagnosis ( Figure 2 ) although the differences did not reach statistical significance within these analyses ( data not shown ).
← all excerpts
Immune marker changes and risk of multiple myeloma: a nested case-control study using repeated pre-diagnostic blood samples.
1
—
—